KKR completed the acquisition of a majority stake in a biopharma royalty acquisition company, HCRx.

1 report, 1 independent Updated Aug 15

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Kohlberg Kravis Roberts Donald Trump

Keep exploring

Part of

Tariffs are benefiting undervalued AI stocks, highlighted in an investor letter from Greenhaven Road Capital about KKR. All 2 developments

The entities involved

Kohlberg Kravis Roberts
American private equity fund manager

Nothing else this week.
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
- Donald Trump urged John Thune to advance election integrity legislation, specifically regarding the SAVE America Act, while the bill faced blocking in the Senate.10:23
- Trump urged senators to approve legislation while Nancy Mace criticized John Thune for failing to advance the SAVE America Act.10:23

Coverage

Newest first; wire copies grouped

Aug 15Insider MonkeyKKR Acquires Majority Stake in HealthCare Royalty Partners KKR & Co. Inc. (NYSE:KKR) is one of the 11 Best Revenue Growth Stocks to Buy Now. On July 30, KKR & Co. Inc. (NYSE:KKR) announced that it ha